Early research (Phase 1)Study completedNCT02262338
What this trial is testing
Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome
Who this might be right for
Mucopolysaccharidosis II
ArmaGen, Inc 6